Publications by authors named "S A Vuijk"

Claim this Profile
E
Expanding the therapeutic arsenal for paediatric ulcerative colitis.
Stephanie A Vuijk, Esmée H Boute, Lissy de Ridder

Lancet Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration.
Q Zhao, M M E Jongsma, S A Vuijk, B C M de Winter, C Martinez-Vinson

Clin Pharmacokinet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration.
Q Zhao, M M E Jongsma, S A Vuijk, B C M de Winter, C Martinez-Vinson

Clin Pharmacokinet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations in Paediatric and Adolescent Inflammatory Bowel Disease.
Stephanie A Vuijk, Anouk E Camman, Lissy de Ridder

J Crohns Colitis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Infliximab induction therapy in paediatric Crohn's disease - A cost-effective strategy? Authors' reply.
Stephanie A Vuijk, Lissy de Ridder

Aliment Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis